Cells and tissue interactions with glycated collagen and their relevance to delayed diabetic wound healing

Biomaterials

Volumn 30, Issue 9, 2009, Pages 1689-1696

  Liao, Huijuan ^a   Zakhaleva, Julia ^b   Chen, Weiliam ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Collagen matrix; Fibroblast; Glycation; In vitro model

Indexed keywords

ADVANCED GLYCATION END PRODUCTS; CHRONIC WOUNDS; COLLAGEN MATRIX; CYTOSKELETONS; EXTRA CELLULAR MATRICES; FIBROBLAST; GLYCATION; IMMUNOSTAINING; IN VITRO MODEL; IN-VIVO; NEW APPROACHES; TISSUE INTERACTIONS; UNDERLYING CAUSE; WOUND-HEALING;

BIOMECHANICS; CELL CULTURE; FIBROBLASTS; HISTOLOGY; MECHANICAL PROPERTIES; MECHANISMS; SUGAR (SUCROSE); TISSUE;

COLLAGEN;

ACTIN; ADVANCED GLYCATION END PRODUCT; COLLAGEN; GLYOXYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CHRONIC WOUND; CYTOSKELETON; DIABETES MELLITUS; EXTRACELLULAR MATRIX; FIBROBLAST; GLYCATION; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE INTERACTION; WOUND HEALING IMPAIRMENT;

ACTINS; ANIMALS; BIOMECHANICS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SHAPE; COLLAGEN; CYTOSKELETON; DERMIS; DIABETES MELLITUS; EXTRACELLULAR MATRIX; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOSYLATION; IMPLANTS, EXPERIMENTAL; MICE; WOUND HEALING;

MUS;

EID: 58849121406     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.11.038     Document Type: Article

References (42)

1. Ahmed N. Advanced glycation end products-role in pathology of diabetic complications. Diabetes Res Clin Pract 67 1 (2005) 3-21
2. Singh R., Barden A., Mori T., and Beilin L. Advanced glycation end-products: a review. Diabetologia 44 2 (2001) 129-146
3. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46 (1995) 223-234
4. Friedman E.A. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22 Suppl. 2 (1999) B65-B71
5. Ahmed M.U., Brinkmann Frye E., Degenhardt T.P., Thorpe S.R., and Baynes J.W. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324 Pt 2 (1997) 565-570
6. Monnier V.M., Vishwanath V., Frank K.E., Elmets C.A., Dauchot P., and Kohn R.R. Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. N Engl J Med 314 7 (1986) 403-408
7. Vishwanath V., Frank K.E., Elmets C.A., Dauchot P.J., and Monnier V.M. Glycation of skin collagen in type I diabetes mellitus. Correlation with long-term complications. Diabetes 35 8 (1986) 916-921
8. Sell D.R., and Monnier V.M. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J Clin Invest 85 2 (1990) 380-384
9. Monnier V.M., Sell D.R., Nagaraj R.H., Miyata S., Grandhee S., Odetti P., et al. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 41 Suppl. 2 (1992) 36-41
10. Vasan S., Foiles P., and Founds H. Therapeutic potential of breakers of advanced glycation end product-protein crosslinks. Arch Biochem Biophys 419 1 (2003) 89-96
11. Monnier V.M., and Sell D.R. Prevention and repair of protein damage by the Maillard reaction in vivo. Rejuvenation Res 9 2 (2006) 264-273
12. Nicholls K., and Mandel T.E. Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine. Lab Invest 60 4 (1989) 486-491
13. Niu Y., Xie T., Ge K., Lin Y., and Lu S. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products. Am J Dermatopathol 30 4 (2008) 344-351
14. Nilsson B.O. Biological effects of aminoguanidine: an update. Inflamm Res 48 10 (1999) 509-515
15. Stracke H., Lindemann A., and Federlin K. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 104 4 (1996) 311-316
16. Cameron N.E., Cotter M.A., Dines K., and Love A. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35 10 (1992) 946-950
17. Dorrian C.A., Cathcart S., Clausen J., Shapiro D., and Dominiczak M.H. Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell Mol Biol (Noisy-le-grand) 44 7 (1998) 1069-1079
18. Ruszczak Z. Effect of collagen matrices on dermal wound healing. Adv Drug Deliv Rev 55 12 (2003) 1595-1611
19. McCall T.D., Fults D.W., and Schmidt R.H. Use of resorbable collagen dural substitutes in the presence of cranial and spinal infections-report of 3 cases. Surg Neurol 70 1 (2008) 92-96
20. Grigoryants V., Jane Jr. J.A., and Lin K.Y. Salvage of a complicated myelomeningocele using collagen (Duragen) and dermal (Alloderm) matrix substitutes. Case report and review of the literature. Pediatr Neurosurg 43 6 (2007) 512-515
21. Zerris V.A., James K.S., Roberts J.B., Bell E., and Heilman C.B. Repair of the dura mater with processed collagen devices. J Biomed Mater Res B Appl Biomater 83 2 (2007) 580-588
22. Narotam P.K., José S., Nathoo N., Taylon C., and Vora Y. Collagen matrix (DuraGen) in dural repair: analysis of a new modified technique. Spine 29 24 (2004) 2861-2867 [discussion: 2868-9]
23. Alikhani Z., Alikhani M., Boyd C.M., Nagao K., Trackman P.C., and Graves D.T. Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 280 13 (2005) 12087-12095
24. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274 44 (1999) 31740-31749
25. Santana R.B., Xu L., Chase H.B., Amar S., Graves D.T., and Trackman P.C. A role for advanced glycation end products in diminished bone healing in type 1 diabetes. Diabetes 52 6 (2003) 1502-1510
26. Ng K.W., Khor H.L., and Hutmacher D.W. In vitro characterization of natural and synthetic dermal matrices cultured with human dermal fibroblasts. Biomaterials 25 14 (2004) 2807-2818
27. Weng L., Pan H., and Chen W. Self-crosslinkable hydrogels composed of partially oxidized hyaluronan and gelatin: in vitro and in vivo responses. J Biomed Mater Res A 85 2 (2008) 352-365
28. Pan H., Jiang H., and Chen W. Interaction of dermal fibroblasts with electrospun composite polymer scaffolds prepared from dextran and poly lactide-co-glycolide. Biomaterials 27 17 (2006) 3209-3220
29. Vande Berg J.S., Robson M.C., and Mikhail R.J. Extension of the life span of pressure ulcer fibroblasts with recombinant human interleukin-1 beta. Am J Pathol 146 5 (1995) 1273-1282
30. Paul R.G., and Bailey A.J. The effect of advanced glycation end-product formation upon cell-matrix interaction. Int J Biochem Cell Biol 31 6 (1999) 653-660
31. Fuji A., Kobayashi S., Yamamoto H., and Tamura T. Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats. Jpn J Pharmacol 53 3 (1990) 331-337
32. Vlassara H., and Palace M.R. Diabetes and advanced glycation end products. J Intern Med 251 2 (2002) 87-101
33. Desmoulière A., and Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines. Cell Motil Cytoskeleton 29 3 (1994) 195-203
34. Tomasek J.J., and Akiyama S.K. Fibroblast-mediated collagen gel contraction does not require fibronectin-alpha 5 beta 1 integrin interaction. Anat Rec 234 2 (1992) 153-160
35. Bell E., Ivarsson B., and Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 76 3 (1979) 1274-1278
36. Gullberg D., Tingström A., Thuresson A.C., Olsson L., Terracio L., Borg T.K., et al. Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res 186 2 (1990) 264-272
37. Reiser K.M. Nonenzymatic glycation of collagen in aging and diabetes. Proc Soc Exp Biol Med 218 1 (1998) 23-37
38. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 10 (1999) 738-746
39. Blakytny R., and Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 23 6 (2006) 594-608
40. Chettibi S., and Ferguson M.W.J. Wound repair: an overview. In: Gallin J.I., and Snyderman R. (Eds). Inflammation: basic principles and clinical correlates. 3rd ed. (1999), Lippincott Williams and Wilkins, Philadelphia 865-881
41. Wang Z., Pan H., Yuan Z., Liu J., Chen W., and Pan Y. Assessment of dermal wound repair after collagen implantation with optical coherence tomography. Tissue Eng Part C Methods 14 1 (2008) 35-45
42. Loots M.A., Lamme E.N., Zeegelaar J., Mekkes J.R., Bos J.D., and Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J Invest Dermatol 111 5 (1998) 850-857